Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04367311 |
|---|---|
| Brief Title: | Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) |
| First Submitted : | April 27, 2020 |
| First Submitted that Met QC Criteria : | April 27, 2020 |
| First Posted : | April 29, 2020 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 8, 2024 |